High-throughput biochemical assays targeting a vital viral protein identified one molecule out of more than 13,000 with promising antiviral activity against SARS-CoV-2.

Several PNNL scientists contributed to the virtual Society of Toxicology meeting in March.

Vigorous and rapid air exchanges might not always be a good thing when it comes to levels of coronavirus particles in a multiroom building, according to a new modeling study.

Night shift work disrupts the natural 24-hour rhythms in the activity of certain cancer-related genes, making workers more vulnerable to damage to their DNA.

As the COVID-19 pandemic continues, PNNL is offering support to its neighbors in the Mid-Columbia region and across Washington State.

PNNL-developed Water Balance Tool estimates consumption for major water end-uses. Understanding the breakout of water use identifies water efficiency opportunities and allows facility managers to spot potential system losses.

Buildings account for around 40 percent of our nation's energy use and consume 75 percent of our nation’s electricity each year. Energy use is also one of the biggest costs for facility owners.

E-cigarette exposure stresses and inflames the lungs of rats, compromising important quality control proteins, according to new research.

In a first-of-its-kind study, PNNL scientists are learning about how e-cigarettes can lead to changes in proteins at the molecular level that could contribute to disease or other health problems.

PNNL’s longstanding grid and buildings capabilities are driving two projects that test transactive energy concepts on a grand scale and lay the groundwork for a more efficient U.S. energy system.

Researchers at PNNL have developed a bacteria testing system called OmniScreen that combines biological and synthetic chemistry with machine learning to hunt down pathogens before they strike.

A zoonotic coronavirus known as SADS-CoV that has killed many pigs has the ability to infect human cells, surprising scientists.

A PNNL engineering team has designed personal protective equipment in support of COVID-19 aid.

The nation’s ability to test for COVID-19 has expanded, thanks to work at Pacific Northwest National Laboratory, where scientists have established the performance of testing equipment to detect the virus.

Researchers from PNNL have helped colleagues at OHSU identify lipid molecules required for Zika infection in human cells. The specific lipids involved could also be a clue to why the virus primarily infects brain tissue.

Biomedical scientist Brian Thrall co-edited the issue published in the journal NanoImpact. Three of the articles in the issue include multiple PNNL authors.

The PNNL chemist is leading a joint effort to study circadian rhythms and the gut microbiome.

Researchers from 25 institutions around the country, including PNNL, are working to find out how exercise changes the molecular makeup of our cells to generate health benefits.

Joint appointments at UW and OSU help PNNL’s Katrina Waters further collaborations in infectious disease and toxicology research.

PNNL computational biologist Bobbie-Jo Webb-Robertson was recently awarded the “Spirit of nPOD award” to acknowledge her hard work in building, coordinating, and leading the Data Science Working Group.